Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from PaxMedica, Inc. ( (PXMD) ).
On April 2, 2025, PaxMedica, Inc. announced the resignation of its Board Chairman Howard J. Weisman, along with directors Karen J. LaRochelle and John Coelho, effective immediately. These departures are linked to transactions reported earlier and do not stem from any disagreements. Weisman will remain as CEO as the company transitions to a wholly-owned subsidiary of PRV, LLC.
More about PaxMedica, Inc.
YTD Price Performance: -55.71%
Average Trading Volume: 47,830
Technical Sentiment Signal: Buy
Current Market Cap: $2,176
For detailed information about PXMD stock, go to TipRanks’ Stock Analysis page.